학술논문

Doxorubicin sensitizes breast cancer cells to natural killer cells in connection with increased Fas receptors
Document Type
Journal
Source
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE; MAR 2022, 49 3, p40 12p.
Subject
Language
English
ISSN
1791244X